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We examined a large French family with autosomal dominant cerebellar ataxia (ADCA) that was excluded from
all previously identified spinocerebellar ataxia genes and loci. The patients—seven women and a 4-year-old boy—
exhibited slowly progressive childhood-onset cerebellar gait ataxia associated with cerebellar dysarthria, moderate
mental retardation (IQ 62–76), and mild developmental delays in motor acquisition. Nystagmus and pyramidal
signs were also observed in some cases. This unique association of clinical features clearly distinguishes this new
entity from other previously described ADCA. Cerebral magnetic-resonance imaging showed moderate cerebellar
and pontine atrophy in two patients. We performed a genomewide search and found significant evidence for linkage
to chromosome 19q13.3-q13.4, in an ∼8-cM interval between markers D19S219 and D19S553.
The autosomal dominant cerebellar ataxias (ADCAs)
comprise a wide spectrum of diseases with variable onset
and different clinical and neuropathological profiles,
reflecting the degree of cerebellar and brain-stem dys-
function or degeneration (Harding 1993). Molecular ge-
netic studies have revealed that ADCAs are genetically
heterogeneous, and 11 different loci have been mapped
so far (Stevanin et al. 2000). Polyglutamine-coding
(CAG)n-repeat expansions are responsible for the disease
in five of its forms (SCA1 [MIM 164400], SCA2 [MIM
183090], SCA3/MJD [MIM 109150], SCA6 [MIM
183086], and SCA7 [MIM 164500]), whereas untran-
slated CAG tracts are suspected in SCA8 (MIM 603680)
and SCA12 (MIM 604326 [Holmes et al. 1999; Koob
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et al. 1999]). The phenotypes associated with the dif-
ferent loci overlap, so that the locus cannot be deduced
on the basis of clinical expression alone (Stevanin et al.
2000). In the French population, ∼40% of ADCAs re-
main unexplained by any of the known loci.
A large French family with cerebellar ataxia was se-
lected. Blood samples of eight patients, six at-risk in-
dividuals, and four spouses were obtained after informed
consent was signed (fig. 1). The patients were examined
at home, except for the youngest affected individual (IV-
1), who was also examined by cerebral magnetic-
resonance imaging (MRI) and electroencephalogra-
phy in pediatric clinics. The mini mental-state (MMS)
examination was performed at home, and IQ was as-
sessed during childhood in patients II-11, III-12, III-14,
and IV-1. A summary of the clinical profile of the eight
patients is given in table 1. The most striking features
were onset in early childhood in all but one patient and
the mild progression of the disease. Cerebellar ataxia
was associated with petit mal epilepsy in the only af-
fected boy. Motor development was delayed: patient III-
1 walked alone only at age 12 years, patient III-12 at
age 3 years, and patients IV-1 and III-14 at age 4 years.
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Figure 1 Partial pedigree of family AAD-045. Haplotypes for seven microsatellite markers spanning ∼8 cM on chromosome 19q are
shown. The haplotype segregating with the disease is boxed. Recombination events are indicated by horizontal arrows. Stars indicate sampled
individuals.
No reliable information on either the age at onset or
developmental delay could be obtained for the three af-
fected women in generation II, since they did not com-
plain of unsteadiness before adulthood. Mental retar-
dation was obvious although mild in generations III and
IV. MMS examination scores were below the patholog-
ical limit of 24/30 in five affected women, except for
one who had a score of 25/30. Intellectual impairment
was mild and global, with IQs of 62–76. There was no
evidence of progressive deterioration. Slight dysmorphia
and short stature were noted in one patient (III-1). Ce-
rebral MRI in patient IV-1 showed cerebellar vermian
atrophy, normal hemispheres, an enlarged fourth ven-
tricle, atrophy of the posterior pons and bulbar thinning
(fig. 2). In patient III-1, electromyogram, brain-stem au-
ditory- and somatosensory-evoked potentials, fundos-
copy, audition, and karyotype were normal, but a hor-
izontal gaze–evoked nystagmus with a vertical downbeat
component was detected by electro-oculography. The
presence of petit mal epilepsy in patient IV-1 was con-
firmed by the presence of a typical spike-wave complex
at 3 cycles/s on electroencephalography.
The striking clinical features in this family are onset
during childhood, very slow disease progression, and
delayed acquisition of motor and cognitive skills. De-
layed attainment of motor milestones has been reported
in some autosomal recessive cerebellar ataxias, such as
in the carbohydrate-deficiency syndrome (Barone et al.
1999), but without progression. Mental retardation is
associated with cerebellar ataxia in the autosomal re-
cessive syndrome of the Cayman Islands (Nystuen et al.
1996) but has never been reported in ADCA. Subcortical
dementia is, however, present in a small subgroup
(!10%) of patients with ADCA with large CAG repeats
at the SCA1, SCA2, and SCA7 loci (Dubourg et al. 1995;
Cancel et al. 1997; David et al. 1998; Trojano et al.
1998; Burk et al. 1999). In addition, the neurological
phenotype in this kindred is a relatively pure cerebellar
ataxia, with dysarthria, nystagmus, and discrete pyram-
idal features. However, additional neurological signs,
such as swallowing difficulties, urinary urgency, and bra-
dykinesia, are observed in patients at age 50 years.
Since epilepsy is present in most patients from families
with SCA10 (Matsuura et al. 1999; Zu et al. 1999), the
petit mal epilepsy in only one member of family AAD-
045 may be coincidental. Pontocerebellar atrophy on
cerebral MRI is common in ADCA and is consistentwith
the progressive course of this neurodegenerative disorder
(Klockgether et al. 1998).
Trinucleotide-repeat expansions in the SCA1, SCA2,
SCA3/MJD, SCA6, SCA7, SCA8, SCA12, and DRPLA
genes were excluded by molecular analysis of the index
Table 1
Clinical Features in Family AAD-045
Patient (Sex)
Age at
Examination
(years)
Age at
Onset
(years) Disability
Cerebellar
Ataxia (Upper Limbs) Dysarthria Increased Reflexes Nystagmus Mental Status Additional Signs
II-2 (F) 61 Childhood Cannot walk
alone (age 38 years)
Moderate (mild) Severe , Plantar flexor Horizontal MMS 25/30 Syncinesias
II-5 (F) 59 45 Wheelchair-bound
(age 55 years)
Severe (mild) Severe  Except at ankles,
unilateral
extensor
Horizontal MMS 23/30 Torticollis, swallowing difficulties, urinary urgency
II-8 (index case) (F) 53 Childhood Cannot run Moderate (none) Mild , Plantar flexor Horizontal MMS 23/30 Generalized bradykinesia, upward gaze palsy, swallowing difficulties, urinary urgency
III-1 (F) 29 !1 Cannot run Moderate (none) Moderate , Increased
muscle tone
Horizontal,
Vertical,
square
waves
Mental retardation Short stature, slight facial dysmorphia
III-11 (F) 31 !4 Cannot run Mild None , Plantar extensor Horizontal MMS 20/30,
IQ 71
III-12 (F) 28 Childhood Cannot run Mild Moderate , Plantar flexor Horizontal MMS 25/30,
IQ 68
III-14 (F) 24 !3 Cannot run Mild Mild , Unilateral plan-
tar extensor
None IQ 62
IV-1 (M) 4 !1 Cannot run Moderate Moderate  None IQ 76 Petit mal epilepsy
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Table 2
Pairwise LOD Scores for the Disease Locus and 13 Chromosome
19 Markers
MARKERS
LOD SCORE AT v =
v AT
Zmax Zmax.0 .01 .05 .1 .2 .3 .4
D19S420 1.84 .29 1.16 1.44 1.44 1.15 .67 .15 1.49
D19S900 1.96 .18 1.05 1.33 1.36 1.09 .63 .15 1.40
D19S219 1.88 .25 1.11 1.39 1.40 1.11 .63 .14 1.45
D19S412 2.37 2.33 2.17 1.95 1.51 1.03 .51 .00 2.37
D19S902 2.97 2.92 2.71 2.44 1.86 1.24 .59 .00 2.97
D19S606 3.10 3.05 2.84 2.58 2.00 1.37 .70 .00 3.10
D19S866 2.54 2.49 2.28 2.02 1.45 .84 .24 .00 2.54
D19S867 3.50 3.44 3.21 2.91 2.26 1.55 .79 .00 3.50
D19S907 2.55 2.50 2.31 2.06 1.53 .97 .38 .00 2.55
D19S904 .59 .57 .52 .46 .33 .21 .10 .00 .59
D19S585 .36 .35 .31 .26 .17 .08 .02 .00 .36
D19S553 3.61 .06 .62 .75 .69 .49 .23 .10 .75
D19S571 3.61 .09 .77 1.04 1.05 .78 .40 .14 1.10
NOTE.—Calculations were performed using allele-specific frequen-
cies in White control. The use of equal allele frequencies only slightly
modified the values in this family.
Figure 2 Cerebral MRI of patient IV-1 at age 5 years. The T1-weighted midsagital (left) and T2-weighted axial (right) sequences show
atrophy in the dorsal part of the cerebellar vermis but normal hemispheres. The fourth ventricle is enlarged. Atrophy is visible in the posterior
part of the pons and the medulla. The cerebral cortex is normal.
case (II-2) (fig. 1). Linkage analyses also excluded the
loci for SCA4 (MIM 600223), SCA5 (MIM 600224),
SCA10 (MIM 603516), and SCA11 (MIM 604432) (Ste-
vanin et al. 1999; authors’ unpublished data). A ge-
nomewide search was performed with the ABI PRISM
version 2 linkage-mapping set (PE Biosystems). PCR am-
plifications of microsatellites were performed either ac-
cording to the manufacturer’s conditions or as described
in the Genome Database. Pairwise and multipoint LOD
scores were calculated using theMLINK and LINKMAP
programs of the computer package FASTLINK version
3.0P (Cottingham et al. 1993; Lathrop et al. 1985) as
described elsewhere (Stevanin et al. 1994), with pene-
trance set at 98% and with equal allele frequencies. Al-
lele frequencies in white subjects (Genome Database)
were used for markers of the candidate region. The re-
sults obtained by the two modes of calculation differed
only slightly.
Since no father-to-son transmissions were observed,
we began the genomewide search with chromosome X
markers, all of which generated significant negative re-
sults, excluding the possibility of a mutation on this
chromosome in this family. After excluding ∼93% of the
autosomes, we obtained positive LOD scores for several
consecutive markers on chromosome 19q. Ten addi-
tional markers from this region, selected from the Ge´-
ne´thon (Dib et al. 1996) and Center for Medical Ge-
netics, Marshfield Medical Research Foundation genetic
maps (Broman et al. 1998), were then tested to confirm
and refine the genetic localization. A maximum LOD
score (Zmax) of 3.50 at recombination fraction (v) =
was obtained for marker D19S867 (table 2). Mul-.00
tipoint analyses with seven markers spanning the
D19S219–D19S553 interval localized the disease-caus-
ing gene to a region between these markers and gener-
ated at marker D19S867 (fig. 3). A singleZ = 3.85max
haplotype segregated with the disease. Recombination
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Figure 3 Multipoint linkage analysis with seven chromosome 19q markers: D19S219/D19S412–3 cM–D19S902/D19S606–1 cM–
D19S867–2 cM–D19S585–2 cM–D19S553. Because of computer limitations, three overlapping multipoint calculations, using D19S219-
D19S412-D19S902, D19S902-D19S606-D19S867, and D19S867-D19S585-D19S553, were performed to generate this curve. The LOD scores
obtained in the overlapping regions were similar in all analyses.
events in patients II-5 and IV-1 excluded markers
D19S219 and D19S553, respectively, delimiting an ∼8-
cM region on chromosome 19q13.3-q13.4 (fig. 1).
Onset occurred during childhood in all generations;
unlike the situation for other ADCAs, there was no ev-
idence of anticipation. In ADCAs caused by polygluta-
mine expansions, childhood onset is always associated
with large CAG-repeat expansions and rapid disease
progression. To determine whether the mutation in this
family is a CAG/polyglutamine-repeat expansion, rapid
expansion detection (RED) analyses were performed on
patients III-12 and IV-1, as described elsewhere (Zander
et al. 1998). Furthermore, proteins were extracted, ac-
cording to two different protocols (Stevanin et al. 1996),
from immortalized lymphoblasts of four patients with
early onset and/or marked severity of the disease (II-5,
II-8, III-11, and III-14). The extracts were electropho-
resed and blotted onto cellulose membranes, then hy-
bridized with the 1C2 antibody, which selectively rec-
ognizes large polyglutamine-repeat tracts (Trottier et al.
1995). Consistent with the clinical observations, we
found no large CAG/polyglutamine-repeat sequences in
the members of the family tested. The 1C2 antibody
labeled no specific proteins containing a polyglutamine
expansion on the Western blots. RED analysis of ge-
nomic DNA revealed no ligation products corresponding
to CAG/CTG repeats 140 units (data not shown). Both
methods, however, detect only relatively large expan-
sions; therefore, a small CAG repeat, as in SCA6 (Zhu-
chenko et al. 1997), or another type of trinucleotide-
repeat expansion cannot be excluded.
In conclusion, we have mapped, on human chromo-
some 19, the locus responsible for a new phenotype of
ADCA with mental retardation: a phenotype that we
propose to designate as “spinocerebellar ataxia 13”
(SCA13). This family extends the spectrum of clinical
features associated with ADCA. Since the clinical syn-
drome in this family does not correspond to any of the
three types of ADCA described by Harding, it therefore
might represent a new clinical and genetic entity.
Several genes have been identified in the 8-cM region
on 19q, including those for Bcl-2–associated X protein
(BAX), phospholipase A2 (PLA2G4C), and calmodulin
(CALM3), which are potential candidates. However, the
clinical course of the disorder, in which delayed motor
and mental development are observed before the onset
of progressive ataxia, suggests that the responsible gene
might be involved in both the development and main-
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tenance and/or survival of specific neuronal populations.
The 8-cM candidate region defined by haplotype recon-
struction and multipoint analysis is still large. Additional
families with linkage to this locus, as well as the devel-
opment of new markers, are needed to refine the can-
didate interval.
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